Walleye Capital LLC Tandem Diabetes Care Inc Call Options Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$30.43 - $53.43 $1.17 Million - $2.05 Million	38,400 Added 12800.0%	38,700 $1.56 Million
Q1 2024 May 15, 2024	SELL	$22.09 - $35.41 $669,327 - $1.07 Million	-30,300 Reduced 99.02%	300 $10,000
Q4 2023 Feb 14, 2024	BUY	$14.28 - $31.03 $345,576 - $750,926	24,200 Added 378.13%	30,600 $905,000
Q2 2023 Aug 14, 2023	BUY	$24.18 - $42.46 $82,212 - $144,364	3,400 Added 113.33%	6,400 $157,000
Q1 2023 May 15, 2023	BUY	$35.86 - $46.5 $107,580 - $139,500	3,000 New	3,000 $121,000
Q3 2019 Nov 14, 2019	SELL	$57.11 - $73.3 $845,228 - $1.08 Million	-14,800 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$54.41 - $71.7 $223,081 - $293,970	4,100 Added 38.32%	14,800 $955,000
Q1 2019 May 15, 2019	BUY	$32.25 - $73.56 $345,075 - $787,092	10,700 New	10,700 $679,000

347

73M

3.12M

343K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.11B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.